Impaired early B cell tolerance in patients with rheumatoid arthritis

Journal of Experimental Medicine

Volumn 201, Issue 10, 2005, Pages 1659-1667

  Samuels, Jonathan ^a   Ng, Yen Shing ^a   Coupillaud, Claire ^a   Paget, Daniel ^a   Meffre, Eric ^a,b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; RECOMBINANT ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; MALE; MOLECULAR CLONING; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; BONE MARROW; CELL DIFFERENTIATION; CITRULLINE; FEMALE; HUMANS; IMMUNE TOLERANCE; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 19344374510     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20042321     Document Type: Article

References (51)

1. Feldmann, M., F.M. Brennan, and R.N. Maini. 1996. Rheumatoid arthritis. Cell. 85:307-310.
2. Leslie, D., P. Lipsky, and A.L. Notkins. 2001. Autoantibodies as predictors of disease. J. Clin. Invest. 108:1417-1422.
3. Smolen, J.S., and G. Steiner. 2001. Rheumatoid arthritis is more than cytokines: autoimmunity and rheumatoid arthritis. Arthritis Rheum. 44:2218-2220.
4. Sebbag, M., M. Simon, C. Vincent, C. Masson-Bessiere, E. Girbal, D. Jean-Jacques, and E. Serre. 1995. The anti-perinuclear factor and the so-called anti-keratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 95:2672-2679.
5. Schellekens, G.A., B.A.W. de Jong, F.H.J. van den Hoogen, L.B.A. van de Putte, and W.J. van Venrooij. 1998. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101:273-281.
6. Rantapaa-Dahlqvist, S., B.A.W. de Jong, E. Berglin, G. Hallmans, G. Wadell, H. Stenlund, U. Sundin, and W.J. van Venrooij. 2003. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48:2741-2749.
7. Kouskoff, V., A.S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell. 87:811-822.
8. Sakaguchi, N., T. Takahashi, H. Hata, T. Nomura, T. Tagami, S. Yamazaki, T. Sakihama, T. Matsutani, I. Negishi, S. Nakatsuru, and S. Sakaguchi. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 426:454-460.
9. Silverman, G.J., and S. Weisman. 2003. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum. 48:1484-1492.
10. Edwards, J.C.W., L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, D.R. Close, R.M. Stevens, and T. Shaw. 2004. Efficacy of B cell-targeted therapy with Rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350:2572-2581.
11. Victor, K.D., I. Randen, K. Thompson, O. Forre, J.B. Natvig, S.M. Fu, and J.D. Capra. 1991. Rheumatoid factors isolated from patients with autoimmune disorders are derived from germline genes distinct from those encoding the Wa, Po, and Bla cross-reactive idiotypes. J. Clin. Invest. 87:1603-1613.
12. Bridges, S.L., Jr., S.K. Lee, M.L. Johnson, J.C. Lavelle, P.G. Fowler, W.J. Koopman, and H.W. Schroeder Jr. 1995. Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals. J. Clin. Invest. 96:831-841.
13. Wardemann, H., S. Yurasov, A. Schaefer, J.W. Young, E. Meffre, and M.C. Nussenzweig. 2003. Predominant autoamibody production by early human B cell precursors. Science. 301:1374-1377.
14. Ng, Y.-S., H. Wardemann, J. Chelnis, C. Cunningham-Rundles, and E. Meffre. 2004. Bruton's tyrosine kinase (Btk) is essential for human B cell tolerance. J. Exp. Med. 200:927-934.
15. Sims, G.P., R. Ettinger, Y. Shirota, C.H. Yarboro, G.G. Illei, and P. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood. 10.1182/blood-2004-11-4284.
16. Prak, E.L., and M. Weigert. 1995. Light chain replacement: a new model for antibody gene rearrangement. J. Exp. Med. 182:541-548.
17. Meffre, E., A. Schaefer, H. Wardemann, P. Wilson, E. Davis, and M.C. Nussenzweig. 2004. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J. Exp. Med. 199:145-150.
18. Nemazee, D.A., and K. Burki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 337:562-566.
19. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J. Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wotherspoon, R.H. Lobby, K. Raphael, et al. 1988. Altered immunoglobuhn expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 334:676-682.
20. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999-1008.
21. Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009-1020.
22. Radic, M.Z., J. Erickson, S. Litwin, and M. Weigert. 1993. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177:1165-1173.
23. Bensimon, C., P. Chastagner, and M. Zouali. 1994. Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements. EMBO J. 13:2951-2962.
24. Suzuki, N., T. Harada, S. Mihara, and T. Sakane. 1996. Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus. J. Clin. Invest. 98:1843-1850.
25. Dorner, T., S.J. Foster, N.L. Farner, and P.E. Lipsky. 1998. Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. J. Clin. Invest. 102:688-694.
26. Melamed, D., and D. Nemazee. 1997. Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc. Natl. Acad. Sci. USA. 94:9267-9272.
27. Hertz, M., and D. Nemazee. 1997. BCR ligation induces receptor editing in IgM+IgD- bone marrow B cells in vitro. Immunity. 6:429-436.
28. Tze, L.E., K.L. Hippen, and T.W. Behrens. 2003. Late immature B cells (IgM(high)IgD(neg)) undergo a light chain receptor editing response to soluble self-antigen. J. Immunol. 171:678-682.
29. de Weers, M., G.S. Brouns, S. Hinshelwood, C. Kinnon, R.K. Schuurman, R.W. Hendriks, and J. Borst. 1994. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J. Biol. Chem. 269:23857-23860.
30. Kurosaki, T., and S. Tsukada. 2000. BLNK: connecting Syk and Btk to calcium signals. Immunity. 12:1-5.
31. Liossis, S.N., B. Kovacs, G. Dennis, G.M. Kammer, and G.G. Tsokos. 1996. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J. Clin. Invest. 98:2549-2557.
32. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M.C. Nussenzweig. 2005. Defective B cell tolerance check-points in systemic lupus erythematosus. J. Exp. Med. 201:703-711.
33. Begovich, A.B., V.E.H. Carlton, L.A. Honigberg, S.J. Schrodi, A.P. Chokkalingam, H.C. Alexander, K.G. Ardlie, Q. Huang, A.M. Smith, J.M. Spoerke, et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75:330-337.
34. Kyogoku, C., C.D. Langfeld, W.A. Ortmann, A. Lee, S. Selby, V.E.H. Carlton, M. Chang, P. Ramos, E.C. Baechler, P.M. Batliwalla, et al. 2004. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75:504-507.
35. Wasserman, R., Y.S. Li, and R.R. Hardy. 1997. Down-regulation of terminal deoxynucleotidyl transferase by Ig heavy chain in B lineage cells. J. Immunol. 158:1133-1138.
36. Ghia, P., E. ten Boekel, E. Sanz, A. de la Hera, A. Rolink, and F. Melchers. 1996. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain loci. J. Exp. Med. 184:2217-2229.
37. Campana, D., J. Farrant, N. Inamdar, A.D. Webster, and G. Janossy. 1990. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J. Immunol. 145:1675-1680.
38. Meffre, E., M. Milili, C. Blanco-Betancourt, H. Antunes, M.C. Nussenzweig, and C. Schiff. 2001. Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J. Clin. Invest. 108:879-886.
39. Cyster, J.G., S.B. Hartley, and C.C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature. 371:389-395.
40. Cyster, J.G., and C.C. Goodnow. 1995. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity. 3:691-701.
41. Russell, D.M., Z. Denibic, G. Morahan, J.F.A.P. Miller, K. Bürki, and D. Nemazee. 1991. Peripheral deletion of self-reactive B cells. Nature. 354:308-311.
42. Gu, H., D. Tarlinton, W. Muller, K. Rajewsky, and I. Forster. 1991. Most peripheral B cells in mice are ligand selected. J. Exp. Med. 173:1357-1371.
43. Levine, M.H., A.M. Haberman, D.B. Sant'Angelo, L.G. Hannum, M.P. Cancro, C.A. Janeway Jr., and M.J. Shlomchik. 2000. A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc. Natl. Acad. Sci. USA. 97:2743-2748.
44. Lesley, R., Y. Xu, S.L. Kalled, D.M. Hess, S.R. Schwab, H.-B. Shu, and J.G. Cyster. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 20:441-453.
45. Thien, M., T.G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 20:785-798.
46. Groom, J., S.L. Kalled, A.H. Cutler, C. Olson, S.A. Woodcock, P. Schneider, J. Tschopp, T.G. Cachero, M. Batten, J. Wheway, et al. 2002. Association of BAFF/BLys overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109:59-68.
47. Leadbetter, E.A., I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:603-607.
48. Viglianti, G.A., C.M. Lau, T.M. Hanley, B.A. Miko, M.J. Shlomchik, and A. Marshak-Rothstein. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity. 19:837-847.
49. Hill, J.A., S. Southwood, A. Sette, A.M. Jevnikar, D.A. Bell, and E. Cairns. 2003. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DBRB1*0401 MHC class II molecule. J. Immunol. 171:538-541.
50. Shlomchik, M.J., A. Marshak-Rothstein, C.B. Wolfowicz, T.L. Rothstein, and M.G. Weigert. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature. 328:805-811.
51. Weyand, C.M., and J.J. Goronzy. 2003. Ectopic germinal center formation in rheumatoid synovitis. Ann. NY Acad. Sci. 987:140-149.